---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-009086"
form_type: "8-K"
ticker: "CRBP"
cik: "0001595097"
company_name: "Corbus Pharmaceuticals Holdings, Inc."
filed_at: "2024-01-31T23:59:59+00:00"
generated_at: "2026-06-06T13:32:22.822523+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Corbus suspends ATM equity offering program, terminates Jan 29 prospectus supplement

## Summary
- Suspended and terminated the ATM prospectus supplement dated Jan 29, 2024, under Sale Agreement with Jefferies.
- No sales of common stock until a new prospectus supplement is filed.
- The underlying Sale Agreement dated August 6, 2020, remains in full force and effect.

## SEC filing metadata
- accession: 0000950170-24-009086
- form_type: 8-K
- ticker: CRBP
- cik: 0001595097
- company_name: Corbus Pharmaceuticals Holdings, Inc.
- filed_at: 2024-01-31T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1595097/000095017024009086/0000950170-24-009086-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1595097/000095017024009086/crbp-20240130.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-009086
- JSON: https://secwatch.observer/filing/0000950170-24-009086.json
- Plain text: https://secwatch.observer/filing/0000950170-24-009086.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.